Diagnostic Accuracy of Tuberculosis Screening Tests in a Prospective Multinational Cohort: Chest Radiography With Computer-Aided Detection, Xpert Tuberculosis Host Response, and C-Reactive Protein
Clinical Infectious Diseases · 25.02.2026 · 82 (2) · e239-e247
DOI: 10.1093/cid/ciae549 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Clinical Infectious Diseases, online erschienen am 07.11.2024. Verfasst von Rebecca Crowder und 18 weiteren Autor:innen. Beteiligte Einrichtung: Center for Tuberculosis and Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, San Francisco, California, USA. Hauptthemen laut MEDLINE: C-Reactive Protein, Radiography, Thoracic, Mass Screening, Tuberculosis, Pulmonary. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, National Institute of Allergy and Infectious Diseases, Foundation for Innovative New Diagnostics.
Abstract (Originalsprache)
Background
Accessible, accurate screening tests are necessary to advance tuberculosis case finding and early detection in high-burden countries.
Methods
We prospectively screened adults with ≥2 weeks of cough at primary health centers in the Philippines, Vietnam, South Africa, Uganda, and India. Participants underwent chest radiography, Cepheid Xpert TB Host Response (Xpert HR) testing, and point-of-care C-reactive protein (CRP) testing (Boditech). Chest radiographs were processed using CAD4TB v7, a computer-aided detection (CAD) algorithm. We assessed diagnostic accuracy against a microbiologic reference standard (sputum Xpert Ultra, culture). Optimal cutoff points were chosen to maximize specificity at 90% sensitivity. Two-test screening algorithms were considered, using (1) sequential negative serial screening (with positive defined as positive on either test) and (2) sequential positive serial screening (with positive defined as positive on both tests).
Results
Between July 2021 and August 2022, a total of 1392 participants with presumptive tuberculosis had valid index tests and reference standard results, and 303 (22%) had confirmed tuberculosis. In head-to-head comparisons, CAD4TB v7 showed the highest specificity at 90% sensitivity (70.3% vs 65.1% for Xpert HR [95% confidence interval for absolute difference in specificity, 1.6%–8.9%] and vs 49.7% for CRP [17.0%–24.3%]). Three 2-test screening algorithms met World Health Organization target product profile minimum accuracy thresholds and had higher accuracy than any test alone. At 90% sensitivity, the specificity was 79.6% for Xpert HR–CAD4TB (sequential negative), 75.9% for CRP-CAD4TB (sequential negative), and 73.7% for Xpert HR–CAD4TB (sequential positive).
Conclusions
CAD4TB achieves target product profile targets and outperforms Xpert HR and CRP. Combining screening tests further increased accuracy. Clinical Trials Registration. NCT04923958
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Tuberculosis and Division of Pulmonary and Critical Care Medicine, University of California, San Francisco, San Francisco, California, USA.
- Department of Pulmonary Medicine, Christian Medical College, Vellore, India.
- Department of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
- Department of Microbiology and Parasitology, College of Medicine, De la Salle Medical and Health Sciences Institute, Dasmariñas, Philippines.
- DSI-NRF Centre of Excellence for Biomedical Tuberculosis Research, South African Medical Research Council Centre for Tuberculosis Research, Division of Molecular Biology and Human Genetics, Faculty of Medicine and Healt…
- TB Programme, FIND, Geneva, Switzerland.
ORCID-Profile: Rebecca Crowder, Balamugesh Thangakunam, Alfred Andama, Devasahayam J Christopher, Victoria Dalay, Welile Nwamba, Sandra V Kik, Dong Van Nguyen, Nguyen Viet Nhung, Morten Ruhwald, Grant Theron, William Worodria, Payam Nahid, Adithya Cattamanchi, Ankur Gupta-Wright, Claudia M Denkinger
Förderung
- NIAID NIH HHS
- National Institute of Allergy and Infectious Diseases
- Foundation for Innovative New Diagnostics
- NIH
Zitieren
APA
Crowder, R., Thangakunam, B., Andama, A., Christopher, D. J., Dalay, V., Nwamba, W., Kik, S. V., Van Nguyen, D., Viet Nhung, N., Phillips, P. P. J., Ruhwald, M., Theron, G., Worodria, W., Yu, C., Nahid, P., Cattamanchi, A., Gupta-Wright, A., Denkinger, C. M., & R2D2 TB Network (2026). Diagnostic Accuracy of Tuberculosis Screening Tests in a Prospective Multinational Cohort: Chest Radiography With Computer-Aided Detection, Xpert Tuberculosis Host Response, and C-Reactive Protein. Clinical Infectious Diseases, 82(2), e239-e247. https://doi.org/10.1093/cid/ciae549
Vancouver
Crowder R, Thangakunam B, Andama A, Christopher DJ, Dalay V, Nwamba W, et al. Diagnostic Accuracy of Tuberculosis Screening Tests in a Prospective Multinational Cohort: Chest Radiography With Computer-Aided Detection, Xpert Tuberculosis Host Response, and C-Reactive Protein. Clinical Infectious Diseases. 2026;82(2):e239-e247. doi:10.1093/cid/ciae549
BibTeX
@article{Crowder2026,
author = {Crowder, Rebecca and Thangakunam, Balamugesh and Andama, Alfred and Christopher, Devasahayam J and Dalay, Victoria and Nwamba, Welile and Kik, Sandra V and Van Nguyen, Dong and Viet Nhung, Nguyen and Phillips, Patrick P J and Ruhwald, Morten and Theron, Grant and Worodria, William and Yu, Charles and Nahid, Payam and Cattamanchi, Adithya and Gupta-Wright, Ankur and Denkinger, Claudia M and R2D2 TB Network, R2D2 TB Network},
title = {Diagnostic Accuracy of Tuberculosis Screening Tests in a Prospective Multinational Cohort: Chest Radiography With Computer-Aided Detection, Xpert Tuberculosis Host Response, and C-Reactive Protein},
journal = {Clinical Infectious Diseases},
year = {2026},
volume = {82},
number = {2},
pages = {e239--e247},
doi = {10.1093/cid/ciae549}
}
EUVIMED